{"nct_id":"NCT01495026","title":"A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2011-11-06","start_date_type":"ACTUAL","primary_completion_date":"2012-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2012-04-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}